C181569Level 7
Daratumumab/Dexamethasone/Selinexor Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of selinexor, dexamethasone and daratumumab that may be used for the treatment of relapsed or refractory plasma cell (multiple) myeloma.
**Synonyms:** - Daratumumab-Dexamethasone-Selinexor - Daratumumab-Dexamethasone-Selinexor Regimen - Daratumumab/Dexamethasone/Selinexor - Darzalex/Dexamethasone/Xpovio - SDd - Selinexor/Dexamethasone Plus Daratumumab - Selinexor/Dexamethasone Plus Daratumumab Regimen
GET
/api/v1/systems/nci_thesaurus/nodes/C181569Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.